Advertisement


Levi Garraway, MD, PhD, on Drug Development and the Cost of Researching and Treating Cancer

The Policy, Politics & Law of Cancer

Advertisement

Levi Garraway, MD, PhD, Senior Vice President, Global Development & Medical Affairs, Eli Lilly, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Cancer at The Policy, Politics and Law of Cancer, presented by The Solomon Center for Health Law and Policy at Yale Law School, in collaboration with Smilow Cancer Hospital and Yale Cancer Center.



Related Videos

Health-Care Policy

Nancy Goodman, JD, MPP: Is the Federal Government a Productive Partner in Cancer Policy?

Nancy Goodman, JD, MPP, Executive Director, Kids V Cancer, speaks during Panel 1: Is the Federal Government a Productive Partner in Cancer Policy? at The Policy, Politics ...

Issues in Oncology

Ed Benz, MD, on The Business of Cancer

Ed Benz, MD, President and CEO Emeritus, Dana-Farber Cancer Institute, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cancer, presented b...

Issues in Oncology
Cost of Care

Peter Bach, MD, MAPP, on Drug Development and the Cost of Researching and Treating Cancer

Peter Bach, MD, MAPP, Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, speaks during Panel 4: Drug Development and the Cost of Res...

Issues in Oncology
Cost of Care

Jeffrey Schwartz, MBA, on Drug Development and the Cost of Researching and Treating Cancer

Jeffrey Schwartz, MBA, Managing Director, Bain Capital Life Sciences, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Cancer at The Policy...

Issues in Oncology

Randall Oyer, MD, on The Business of Cancer

Randall Oyer, MD, Medical Director, Oncology Program, Lancaster General Hospital, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cancer, ...

Advertisement

Advertisement



Advertisement